Fennik Life Sciences, LLC, founded by Drs. Nikki Cheng and Wei Bin Fang in early 2016, is a life science company focused on developing innovative research tools and solutions for the scientific community. By improving pre-clinical research methods and tools, we can better advance scientific knowledge of diseases, and develop safer and more effective treatments for clinical trial testing. The Therakan is the first 3D culture system platform from Fennik Life Sciences. Our innovative novel system overcomes key limitations of conventional 3D cell culture platforms and creates physiologically relevant immune microenvironments for rapid and thorough analysis for drug efficacy, toxicology, ADME, pre-clinical drug screening research and tissue/cell research. We specialize in lab services that includes validate drugs or drugs or drug targets in animal or human cells, measure the efficacy, toxicity, stability and penetration of drugs or drug targets, and assess cellular or molecular mechanisms.